Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Extracellular vesicles as a circulating biomarker for cerebrovascular dysfunction in heart failure

FY 2022-23

Summary
A heart attack causes severe damage to the heart and can also compromise brain function. Heart failure (HF) patients with reduced ejection fraction experience inflammation, reduced perfusion in the brain vasculature, and cognitive impairment. It is not known if this is accompanied by disruption to endothelial cells (ECs) of the blood-brain barrier (BBB). Extracellular vesicles (EV) are membranous particles important for cell-to-cell communication. Disruptions to normal physiology changes EV content and production, which can be measured in circulation. To date, there are no EV markers specific to cerebrovascular ECs. EV cargo could be utilized as an early circulating biomarker for assessing cognitive impairment risk in HF patients by screening for biomarkers specific to cerebral microvascular dysfunction. To identify the utility of EVs as a diagnostic tool for cerebral dysfunction in HF patients the project will have two aims. Aim one: Determine the severity of BBB impairment and leakage in a well-established mouse model of HF by using permeability markers and light sheet microscopy to assess the degree of barrier impairment. Aim two: Characterize EVs from ECs in various microvascular beds to identify markers specific to cerebral microvasculature ECs under healthy conditions or when challenged with an inflammatory stimulus, a common pathophysiology seen in HF. Identified markers will be assessed in our mouse HF model. Significance: By investigating BBB permeability in HF and identifying cerebral microvascular EC-specific EV markers, my project will establish whether EVs can be utilized as a diagnostic tool for cognitive impairment in HF patients, potentially informing treatment strategies to improve clinical outcomes.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486165
Name
Park Suejean
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Extracellular vesicles as a circulating biomarker for cerebrovascular dysfunction in heart failure
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Blood-Brain Barrier; Cognitive Impairment; Endothelial Cells; Extracellular Vesicles; Heart Failure; Myocardial Infarction
Abstract
A heart attack causes severe damage to the heart and can also compromise brain function. Heart failure (HF) patients with reduced ejection fraction experience inflammation, reduced perfusion in the brain vasculature, and cognitive impairment. It is not known if this is accompanied by disruption to endothelial cells (ECs) of the blood-brain barrier (BBB). Extracellular vesicles (EV) are membranous particles important for cell-to-cell communication. Disruptions to normal physiology changes EV content and production, which can be measured in circulation. To date, there are no EV markers specific to cerebrovascular ECs. EV cargo could be utilized as an early circulating biomarker for assessing cognitive impairment risk in HF patients by screening for biomarkers specific to cerebral microvascular dysfunction. To identify the utility of EVs as a diagnostic tool for cerebral dysfunction in HF patients the project will have two aims. Aim one: Determine the severity of BBB impairment and leakage in a well-established mouse model of HF by using permeability markers and light sheet microscopy to assess the degree of barrier impairment. Aim two: Characterize EVs from ECs in various microvascular beds to identify markers specific to cerebral microvasculature ECs under healthy conditions or when challenged with an inflammatory stimulus, a common pathophysiology seen in HF. Identified markers will be assessed in our mouse HF model. Significance: By investigating BBB permeability in HF and identifying cerebral microvascular EC-specific EV markers, my project will establish whether EVs can be utilized as a diagnostic tool for cognitive impairment in HF patients, potentially informing treatment strategies to improve clinical outcomes.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Park, Suejean
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~